These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 32276641

  • 1. A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas.
    Wimmer M, Zauner R, Ablinger M, Piñón-Hofbauer J, Guttmann-Gruber C, Reisenberger M, Lettner T, Niklas N, Proell J, Sajinovic M, De Souza P, Hainzl S, Kocher T, Murauer EM, Bauer JW, Strunk D, Reichelt J, Mellick AS, Wally V.
    Cell Commun Signal; 2020 Apr 10; 18(1):61. PubMed ID: 32276641
    [Abstract] [Full Text] [Related]

  • 2. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
    Föll MC, Fahrner M, Gretzmeier C, Thoma K, Biniossek ML, Kiritsi D, Meiss F, Schilling O, Nyström A, Kern JS.
    Matrix Biol; 2018 Mar 10; 66():1-21. PubMed ID: 29158163
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
    Condorelli AG, Logli E, Cianfarani F, Teson M, Diociaiuti A, El Hachem M, Zambruno G, Castiglia D, Odorisio T.
    Br J Dermatol; 2019 Nov 10; 181(5):1017-1027. PubMed ID: 30816994
    [Abstract] [Full Text] [Related]

  • 4. TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa.
    Knaup J, Gruber C, Krammer B, Ziegler V, Bauer J, Verwanger T.
    Anal Cell Pathol (Amst); 2011 Nov 10; 34(6):339-53. PubMed ID: 22002724
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes.
    Dayal JH, Cole CL, Pourreyron C, Watt SA, Lim YZ, Salas-Alanis JC, Murrell DF, McGrath JA, Stieger B, Jahoda C, Leigh IM, South AP.
    J Cell Sci; 2014 Feb 15; 127(Pt 4):740-51. PubMed ID: 24357722
    [Abstract] [Full Text] [Related]

  • 9. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
    Welponer T, Weber DD, Trattner L, Tockner B, Aminzadeh-Gohari S, Leb-Reichl V, Kaufmann A, Zauner R, Wimmer M, Wally V, Felder TK, Strunk D, Koller U, Bauer JW, Kofler B, Guttmann-Gruber C, Piñon Hofbauer J.
    J Eur Acad Dermatol Venereol; 2024 Jan 15; 38(1):112-123. PubMed ID: 37669776
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Rodeck U, Fertala A, Uitto J.
    Exp Dermatol; 2007 Jun 15; 16(6):465-7. PubMed ID: 17518985
    [Abstract] [Full Text] [Related]

  • 12. miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma.
    Gastaldi C, Bertero T, Xu N, Bourget-Ponzio I, Lebrigand K, Fourre S, Popa A, Cardot-Leccia N, Meneguzzi G, Sonkoly E, Pivarcsi A, Mari B, Barbry P, Ponzio G, Rezzonico R.
    Carcinogenesis; 2014 May 15; 35(5):1110-20. PubMed ID: 24374827
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA expression differs in cutaneous squamous cell carcinomas and healthy skin of immunocompetent individuals.
    Bruegger C, Kempf W, Spoerri I, Arnold AW, Itin PH, Burger B.
    Exp Dermatol; 2013 Jun 15; 22(6):426-8. PubMed ID: 23711067
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I, Espinosa M, Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A, Maldonado V, Melendez-Zajgla J, Garcia‐Lopez P.
    EMBO Rep; 2016 May 15; 17(5):648-58. PubMed ID: 27113763
    [Abstract] [Full Text] [Related]

  • 18. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF, Yu JR, Yang Z, Zhu GX, Gao P, Wang H, Chen SY, Zhang J, Liu MY, Niu Y, Wei XM, Wang W, Ye FJ, Zhang LX, Zhao Y, Sun GG.
    J Exp Clin Cancer Res; 2018 Dec 04; 37(1):301. PubMed ID: 30514328
    [Abstract] [Full Text] [Related]

  • 19. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH, Xiao ZQ, Zhou JD, Yin CQ, Chen ZZ, Tang FJ, Wang SH.
    Cell Cycle; 2020 Jan 04; 19(1):1-14. PubMed ID: 31809227
    [Abstract] [Full Text] [Related]

  • 20. Role of transforming growth factor-β1 in recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    Twaroski K, Chen W, Pickett-Leonard M, Tolar J.
    Exp Dermatol; 2021 May 04; 30(5):664-675. PubMed ID: 33595864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.